Skip to content

Cognitive Anxiety Sensitivity Treatment for Suicide

Development and Evaluation of a Brief, Suicide Prevention Intervention Reducing Anxiety Sensitivity

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01947179
Acronym
CAST
Enrollment
108
Registered
2013-09-20
Start date
2011-09-30
Completion date
2013-02-28
Last updated
2013-09-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anxiety

Brief summary

The purpose of this study is to test the effectiveness and usability of a computer-based treatment for mood and anxiety relevant risk factors. The target of the treatment is related to cognitive stress, which has been shown to be associated with several negative mental health outcomes such as suicidal ideation, substance use disorders, and Post-Traumatic Stress Disorder.

Detailed description

CAST is a newly developed computerized treatment targeting specific risk factors associated with PTSD, substance use, anxiety, and suicide. Eligible individuals will be randomized to one of two conditions. In both conditions, participants will complete various self-report questionnaires and a computerized presentation. Additionally, all participants will be asked to complete a one month follow-up appointment.

Interventions

BEHAVIORALAnxiety Risk Reduction

Involves psychoeducation and interoceptive exposure exercises

Sponsors

United States Department of Defense
CollaboratorFED
Florida State University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* At or above the community sample mean on the ASI * English speakers * 18 years of age or older

Exclusion criteria

* Significant medical illness * Current substance dependence * Current or past psychotic-spectrum disorders * Uncontrolled bipolar disorder * Serious suicidal intent that warranted immediate medical treatment

Design outcomes

Primary

MeasureTime frameDescription
Anxiety Sensitivity Index (ASI)Month one follow-upThe ASI is a 16-item self-report measure of anxiety sensitivity. Each item consists of a possible negative consequence of anxiety symptoms. The scale assesses three AS subfactors including cognitive, physical, and social concerns. The measure has shown good psychometric properties.

Secondary

MeasureTime frameDescription
Beck Suicide Scale (BSS)Month one follow-upThe BSS is a 21-item widely used self-report measure assessing a broad spectrum of behaviors and attitudes related to suicide risk, including suicidal ideation and past suicide attempts. It has demonstrated strong reliability and validity.

Other

MeasureTime frameDescription
Posttraumatic Diagnostic Scale (PDS)Month one follow-upThe PDS is a self-report measure used to assess the severity of posttraumatic stress symptoms during the past month. The measure was designed based on Diagnostic and Statistical Manual-IV criteria. Respondents report if they have experienced any of 12 traumatic events, including an other category, and then indicate which event was the most disturbing. Additionally, respondents rate the frequency of 17 PTSD symptoms experienced in the past month in relation to the most disturbing event they endorsed. The PDS has excellent psychometric properties and can be used as a continuous measure of PTSD symptom severity.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026